This program is targeted at primary care physicians and allied health care providers.
The presentation will provide a brief overview of the evolving management of IBS, with a focus on the emerging data presented at nationally recognized congress meetings
Upon completion of this activity, participants should be able to:
- Apply evidence-based diagnostic criteria to evaluate patients presenting with symptoms suggestive of IBS
- Identify patients with alarm symptoms who require further diagnostic investigation
- Incorporate evidence-based treatment plans for patients with IBS-C, CIC and IBS-D effectively into practice
- Discuss new developments in and data on IBS and CIC treatments
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Purdue University College of Pharmacy and the Gi Health Foundation. Purdue University College of Pharmacy, an equal access/equal opportunity institution, is accredited by the ACCME to provide continuing medical education for physicians.
Purdue University College of Pharmacy estimates the educational activity for a maximum of 1.5 AMA PRA Category 1 Credits ™.
AAFP (American Academy of Family Physicians) Accreditation:
Application for CME credit has been filed with the American Academy of Family Physicians. Determination of credit is pending.
Pharmacist Accreditation Statement:
Purdue University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This is a knowledge based, continuing education activity of Purdue University, an equal access/equal opportunity institution. Universal Activity Number (UAN): 0018-9999-21-006-H01-P, 1.5 contact hours (0.15 CEU).
Release Date: 01/29/21
Expiration Date: 01/29/22
Nursing Accreditation Statement:
Purdue University Continuing Nursing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
This program has been approved for 1.5 contact hours.
All faculty, staff and reviewers involved in the planning, review or presentation of continuing education activities provided by Purdue University College of Pharmacy are required to disclose to the audience any relevant commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.
All additional planning committee members, staff and reviewers of The GI Health Foundation and Purdue University College of Pharmacy have no relationships to disclose.
This program is supported by educational grants from Salix Pharmaceuticals and Takeda Pharmaceuticals U.S.A, Inc.